AEGiS-WSJ: Technology Brief -- UNIMED PHARMACEUTICALS INC.: FDA Approves the Testing Of Drug for AIDS Patients Wall Street JournalImportant note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.
Click here to return to Wall Street Journal main menu




DonateNow



Technology Brief -- UNIMED PHARMACEUTICALS INC.: FDA Approves the Testing Of Drug for AIDS Patients

The Wall Street Journal - 2 April 1996

Unimed Pharmaceuticals Inc. said it received federal Food and Drug Administration approval to begin testing the safety and effectiveness of its drug to treat HIV wasting syndrome. The Buffalo Grove, Ill., pharmaceutical company said the "Phase II" clinical trials of its new product, Androgel-DHT, will be conducted at Beth Israel Hospital in Boston. The company also said the drug, under FDA rules, qualifies for orphan-drug status, which would give Unimed exclusive right to sell the drug for a number of years if it is finally approved. HIV is the virus that causes AIDS. Many AIDS patients suffer from extreme weight loss caused by the disease.

Keywords: AIDS PATIENTS; HIV; WASTING SYNDROME; CLINICAL TRIAL; CAUSES AIDS

KWDaidspatients;hiv;wastingsyndrome;clinicaltrial;causesaids
960402
WJ960402

Copyright © 1996 - The Wall Street Journal. Reproduction of this article (other than one copy for personal reference) must be cleared through the WSJ Permissions Desk.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .